alexa Emerging Technologies In Controlled Long Term Delivery Of Ocular Therapeutics | 20819
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Clinical & Experimental Ophthalmology

Ashim K. Mitra
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
Abstract
Ocular drug delivery remains a challenging task due to restrictive barrier functionalities of the eye structures. Dynamic and static ocular barriers impede transport and efficacy of various topically or systemically administered medications. New technologies for delivery of small molecules and biologics are of growing interest among clinical pharmacologists and pharmaceutical scientists for treating both anterior and posterior segment disorders. The major challenge is to deliver drugs and biologics at therapeutic concentrations to the targeted ocular tissues with minimal side effects. A better understanding of physiological and pathological conditions of the eye along with various methods of delivery would aid in the development of novel therapeutics. Nevertheless, delivery systems that can efficiently target the diseased ocular tissues, generate high drug levels, and maintain prolonged and effective concentrations are highly desirable. Such emerging drug delivery technologies have the potential to maintain and/or improve drug's therapeutic index. It can also boost both patient adherence to chronic therapy and patient outcomes. This symposium will provide both trainees and clinicians with an educational background for the development of novel therapeutic modalities to efficiently overcome major challenges associated with ocular drug delivery. Speakers will cover topics for improving drug penetration through ocular barriers and novel drug delivery approaches for delivering both small molecules and biologics at specific ocular compartments. Current momentum in the development of new drug delivery systems hold a promise towards much improved therapies for the treatment of vision threatening disorders such as age-related macular degeneration (AMD), diabetic macular edema (DME), proliferative vitreoretinopathy (PVR), uveitis and glaucoma. Emerging technologies that would provide controlled long term delivery of ocular therapeutics through less invasive routes for targeting intraocular tissues will be major highlights of this symposium.
Biography
Ocular drug delivery remains a challenging task due to restrictive barrier functionalities of the eye structures. Dynamic and static ocular barriers impede transport and efficacy of various topically or systemically administered medications. New technologies for delivery of small molecules and biologics are of growing interest among clinical pharmacologists and pharmaceutical scientists for treating both anterior and posterior segment disorders. The major challenge is to deliver drugs and biologics at therapeutic concentrations to the targeted ocular tissues with minimal side effects. A better understanding of physiological and pathological conditions of the eye along with various methods of delivery would aid in the development of novel therapeutics. Nevertheless, delivery systems that can efficiently target the diseased ocular tissues, generate high drug levels, and maintain prolonged and effective concentrations are highly desirable. Such emerging drug delivery technologies have the potential to maintain and/or improve drug's therapeutic index. It can also boost both patient adherence to chronic therapy and patient outcomes. This symposium will provide both trainees and clinicians with an educational background for the development of novel therapeutic modalities to efficiently overcome major challenges associated with ocular drug delivery. Speakers will cover topics for improving drug penetration through ocular barriers and novel drug delivery approaches for delivering both small molecules and biologics at specific ocular compartments. Current momentum in the development of new drug delivery systems hold a promise towards much improved therapies for the treatment of vision threatening disorders such as age-related macular degeneration (AMD), diabetic macular edema (DME), proliferative vitreoretinopathy (PVR), uveitis and glaucoma. Emerging technologies that would provide controlled long term delivery of ocular therapeutics through less invasive routes for targeting intraocular tissues will be major highlights of this symposium.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7